Antengene (FRA:722) Total Assets : €187.13 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Antengene Total Assets?

Antengene's Total Assets for the quarter that ended in Jun. 2024 was €187.13 Mil.

During the past 12 months, Antengene's average Total Assets Growth Rate was 1.30% per year. During the past 3 years, the average Total Assets Growth Rate was 65.50% per year. During the past 5 years, the average Total Assets Growth Rate was 97.30% per year.

During the past 7 years, Antengene's highest 3-Year average Total Assets Growth Rate was 202.50%. The lowest was 65.50%. And the median was 87.90%.

Total Assets is connected with ROA %. Antengene's annualized ROA % for the quarter that ended in Jun. 2024 was -21.66%. Total Assets is also linked to Revenue through Asset Turnover. Antengene's Asset Turnover for the quarter that ended in Jun. 2024 was 0.04.

Antengene Total Assets Historical Data

The historical data trend for Antengene's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Antengene Total Assets Chart

Antengene Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Assets

Get a 7-Day Free Trial

401.54

355.37

290.06

207.87

176.39

Antengene Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Assets	Get a 7-Day Free Trial								290.06	224.48	207.87	187.13	176.39

Antengene Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Antengene's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	147.356	+	60.516
	=	207.87

Antengene's Total Assets for the quarter that ended in Jun. 2024 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2024 )	+	Total Liabilities (Q: Jun. 2024 )
	=	127.236	+	59.898
	=	187.13

Antengene (FRA:722) Total Assets Explanation

Total Assets is connected with ROA %.

Antengene's annualized ROA % for the quarter that ended in Jun. 2024 is

ROA %	=	Net Income (Q: Jun. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Jun. 2024 ))	/ count )
	=	-42.778	/	( (207.872	+	187.134)	/ 2 )
	=	-42.778	/	197.503
	=	-21.66 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Antengene's Asset Turnover for the quarter that ended in Jun. 2024 is

	Asset Turnover
=	Revenue (Q: Jun. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Jun. 2024 ))	/ count )
=	7.783	/	( (207.872	+	187.134)	/ 2 )
=	7.783	/	197.503
=	0.04

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Antengene Total Assets Related Terms

Thank you for viewing the detailed overview of Antengene's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Antengene Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Antengene Corp Ltd (FRA:722) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

06996:Hong Kong 722:Germany

Address

1065 West Zhongshan Road, Suites 1206-1209, Block B, Zhongshan SOHO Plaza, Changning District, Shanghai, CHN

Website

https://www.antengene.com

Antengene Corp Ltd is a clinical-stage biopharmaceutical company focused on oncology medicines. The company produces drugs such as selinexor, eltanexor, verdinexor, and other products. It also engages in the discovery, development, manufacturing, and commercialization of first-in-class therapeutics for the treatment of hematologic malignancies and solid tumors. Geographically it operates in Chinese Mainland, Hong Kong, Macao and Taiwan and Overseas.

Antengene Headlines

No Headlines